Technology

Patent application No. 10-2025-0097692

This patent relates to a manufacturing method for low- and ultra-low molecular liquid compositions containing active ingredients for blood sugar lowering and improvement of diabetes and obesity, as well as methods for producing foods and pharmaceutical compositions containing them.

Over three years we have developed ultra-micro natural compositions with excellent efficacy in blood sugar reduction and obesity improvement, and consolidated the results of in-vitro and preclinical studies into this patent.

It is a unique, pioneering technology, regarded as the first of its kind domestically and internationally.

The ultra-micro composition dramatically enhances absorption and efficacy, and is expected to become a global leading product in the blood sugar and obesity market, which is estimated at more than 300 trillion KRW.